SynthesisProstate cancer and prostatic diseases2017

Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis.

R J S Calopedos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.